Washizuka; Kenichi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Washizuka; Kenichi.The latest application filed is for "novel dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor".
- Washizuka; Kenichi - Wako JP
- WASHIZUKA; Kenichi - Wako-shi JP
- Washizuka; Kenichi - Chuo-ku JP
- Washizuka; Kenichi - Osaka JP
- Washizuka; Kenichi - Tokyo JP
- Washizuka, Kenichi - Osaka-shi JP
| Patent | Date |
|---|---|
| Compound or pharmaceutically acceptable salt thereof Grant 11,414,429 - Yoshida , et al. August 16, 2 | 2022-08-16 |
| Novel Dihydroquinazolinone Compound Or Pharmacologically Acceptable Salt, And Cell Growth Inhibitor App 20210061789 - YOSHIDA; Minoru ; et al. | 2021-03-04 |
| Anticancer Agent App 20210060016 - SEIMIYA; Hiroyuki ; et al. | 2021-03-04 |
| Novel Compound Or Pharmaceutically Acceptable Salt Thereof App 20200172554 - YOSHIDA; Minoru ; et al. | 2020-06-04 |
| Aminoalcohol derivatives Grant 7,928,264 - Hattori , et al. April 19, 2 | 2011-04-19 |
| Aminoalcohol derivatives Grant 7,417,060 - Hattori , et al. August 26, 2 | 2008-08-26 |
| Aminoalcohol Derivatives App 20080039506 - Hattori; Kouji ; et al. | 2008-02-14 |
| Ornithine derivatives as prostaglandin e2 agonists or antagonists App 20070142638 - Hattori; Kouji ; et al. | 2007-06-21 |
| Aminoalcohol derivatives App 20050137236 - Hattori, Kouji ; et al. | 2005-06-23 |
| Aminoalcohol derivatives and their use as beta 3 adrenergic agonists App 20050043358 - Taniguchi, Kiyoshi ; et al. | 2005-02-24 |
| Aminoalcohol derivatives Grant 6,826,033 - Sakurai , et al. November 30, 2 | 2004-11-30 |
| Aminoalcohol derivatives App 20040138462 - Sakurai, Minoru ; et al. | 2004-07-15 |
| Aminoalcohol derivatives App 20040037022 - Sakurai, Minoru ; et al. | 2004-02-26 |
| Aminoalcohol derivatives App 20030073846 - Taniguchi, Kiyoshi ; et al. | 2003-04-17 |
| Aminoalcohol derivatives App 20030032834 - Kayakiri, Hiroshi ; et al. | 2003-02-13 |
| Aminoalcohol derivatives and their use as beta 3 adrenergic agonists App 20020143034 - Taniguchi, Kiyoshi ; et al. | 2002-10-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 